CIK 0001412408
- Large accelerated filer
Phreesia, Inc.
Sign in to watch- Ticker
- PHR
- Exchange
- NYSE
- Industry
- Services-Business Services, NEC
- FY end
- Jan 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 888-654-7473
- Business address
- 1521 CONCORD PIKE, SUITE 301 PMB 221, WILMINGTON, DE, 19803
- Former names
- Phreesia Inc
- Open-market buys, last 90 days
- $683
- in 1 filing
- Open-market sales, last 90 days
- $67,153
- in 1 filing, $67K under 10b5-1 plans
Net −$66,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-30 | Goldstein Lainie Director | Grant or award | +400 | $24.96 | $10K | 41,855 |
| 2025-04-30 | CAHILL EDWARD L Director | Grant or award | +400 | $24.96 | $10K | 56,273 |
| 2025-04-22 | Hui Yvonne Principal Accounting Officer | Sale 10b5-1 | −1,330 | $23.70 | $32K | 22,592 |
| 2025-04-21 | Linetsky David SVP, Life Sciences | Sale | −260 | $23.04 | $6K | 8,752 |
| 2025-04-21 | Hui Yvonne Principal Accounting Officer | Sale 10b5-1 | −993 | $23.04 | $23K | 23,922 |
| 2025-04-16 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −2,011 | $23.81 | $48K | 219,727 |
| 2025-04-16 | Linetsky David SVP, Life Sciences | Sale 10b5-1 | −2,488 | $23.66 | $59K | 217,239 |
| 2025-04-16 | VanDuyn Amy Beth SVP, Human Resources | Sale | −624 | $23.81 | $15K | 129,820 |
| 2025-04-16 | Roberts Evan Chief Operating Officer | Sale | −1,845 | $23.81 | $44K | 774,807 |
| 2025-04-16 | Indig Chaim Chief Executive Officer | Sale | −3,091 | $23.81 | $74K | 1,254,574 |
| 2025-04-16 | Hui Yvonne Principal Accounting Officer | Sale 10b5-1 | −418 | $23.66 | $10K | 24,915 |
| 2025-04-16 | Hoffman Allison C General Counsel & Secretary | Sale | −1,213 | $23.81 | $29K | 137,921 |
| 2025-04-16 | Gandhi Balaji Chief Financial Officer | Sale | −864 | $23.81 | $21K | 107,547 |
| 2025-04-15 | Hui Yvonne Principal Accounting Officer | Sale 10b5-1 | −314 | $24.04 | $8K | 25,333 |
| 2025-04-09 | Hui Yvonne Principal Accounting Officer | Sale 10b5-1 | −2,802 | $23.23 | $65K | 25,647 |
| 2025-04-09 | Hoffman Allison C General Counsel & Secretary | Sale 10b5-1 | −4,696 | $23.23 | $109K | 139,134 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −2,410 | $23.46 | $57K | 223,272 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −1,534 | $24.48 | $38K | 221,738 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −152 | $23.46 | $4K | 9,108 |
| 2025-04-08 | Linetsky David SVP, Life Sciences | Sale | −96 | $24.48 | $2K | 9,012 |
Page 12 of 15 · 283 trades